Cargando…

Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes

INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple sclerosis (MS). Some patients experience gastrointestinal (GI) adverse events (AEs) that may lead to premature DMF discontinuation. This study characterized the impact of site-specific GI management strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Jinny, Cohan, Stanley, Alvarez, Enrique, Sloane, Jacob, Phillips, J. Theodore, van der Walt, Anneke, Koulinska, Irene, Fang, Fang, Miller, Catherine, Chan, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534646/
https://www.ncbi.nlm.nih.gov/pubmed/30706431
http://dx.doi.org/10.1007/s40120-019-0127-2